Cite
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
MLA
John H. Griffin, et al. Low Level of the Plasma Sphingolipid, Glucosylceramide, Is Associated with Thrombotic Diseases. June 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0953a3ea8f59a17360c28d1a058ce959&authtype=sso&custid=ns315887.
APA
John H. Griffin, Silvia Navarro, Pilar Medina, Darlene J. Elias, Francisco España, Hiroshi Deguchi, W. Craig Hooper, Harland Austin, Nicole F. Dowling, & Amanda B. Payne. (2017). Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.
Chicago
John H. Griffin, Silvia Navarro, Pilar Medina, Darlene J. Elias, Francisco España, Hiroshi Deguchi, W. Craig Hooper, Harland Austin, Nicole F. Dowling, and Amanda B. Payne. 2017. “Low Level of the Plasma Sphingolipid, Glucosylceramide, Is Associated with Thrombotic Diseases,” June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0953a3ea8f59a17360c28d1a058ce959&authtype=sso&custid=ns315887.